IS5594A - A pharmaceutical composition containing an angiotensin II receptor type 2 receptor agonist and its use - Google Patents

A pharmaceutical composition containing an angiotensin II receptor type 2 receptor agonist and its use

Info

Publication number
IS5594A
IS5594A IS5594A IS5594A IS5594A IS 5594 A IS5594 A IS 5594A IS 5594 A IS5594 A IS 5594A IS 5594 A IS5594 A IS 5594A IS 5594 A IS5594 A IS 5594A
Authority
IS
Iceland
Prior art keywords
receptor
angiotensin
pharmaceutical composition
composition containing
receptor agonist
Prior art date
Application number
IS5594A
Other languages
Icelandic (is)
Inventor
Fändriks Lars
Petterson Anders
Hallberg Anders
Original Assignee
Pharmacore Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacore Ab filed Critical Pharmacore Ab
Publication of IS5594A publication Critical patent/IS5594A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS5594A 1998-02-24 2000-08-21 A pharmaceutical composition containing an angiotensin II receptor type 2 receptor agonist and its use IS5594A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9800550A SE9800550D0 (en) 1998-02-24 1998-02-24 A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
PCT/SE1999/000262 WO1999043339A1 (en) 1998-02-24 1999-02-24 A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof

Publications (1)

Publication Number Publication Date
IS5594A true IS5594A (en) 2000-08-21

Family

ID=20410283

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5594A IS5594A (en) 1998-02-24 2000-08-21 A pharmaceutical composition containing an angiotensin II receptor type 2 receptor agonist and its use

Country Status (18)

Country Link
EP (1) EP1066048A1 (en)
JP (1) JP2002504516A (en)
KR (1) KR20010041211A (en)
CN (1) CN1291104A (en)
AU (1) AU755949B2 (en)
BR (1) BR9908188A (en)
CA (1) CA2319123A1 (en)
EE (1) EE200000481A (en)
HU (1) HUP0101411A3 (en)
ID (1) ID26639A (en)
IL (1) IL137990A0 (en)
IS (1) IS5594A (en)
MX (1) MXPA00008172A (en)
NO (1) NO20004215L (en)
NZ (1) NZ506188A (en)
SE (1) SE9800550D0 (en)
SK (1) SK11522000A3 (en)
WO (1) WO1999043339A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821953B1 (en) 1999-12-16 2004-11-23 University Of Southern California Methods for treating and preventing damage to mucosal tissue
AU1793101A (en) * 1999-12-16 2001-06-25 University Of Southern California Methods for treating and preventing damage to mucosal tissue
WO2002096883A1 (en) 2001-05-31 2002-12-05 Vicore Pharma Ab Tricyclic compounds useful as angiotensin ii agonists
KR101488812B1 (en) 2005-04-12 2015-02-02 바이코어 파마 아베 New bicyclic angiotensin II agonist
JP5202301B2 (en) 2005-04-12 2013-06-05 ヴィコール・ファルマ・アーベー Novel tricyclic angiotensin II agonist
DE602006018122D1 (en) 2005-04-12 2010-12-23 Vicore Pharma Ab NEW TRICYCLIC ANGIOTENSIN II AGONISTS
US20080317670A1 (en) * 2005-12-14 2008-12-25 Ambrx, Inc. Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
US8835471B2 (en) 2010-06-11 2014-09-16 Vicore Pharma Ab Use of angiotensin II agonists
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
WO2013158628A1 (en) * 2012-04-16 2013-10-24 New York University Modulation of angiotensin ii peceptors for the prevention and treatment of cerebral malaria
HK1244232A1 (en) 2015-03-02 2018-08-03 维科尔药物公司 Angiotensin ii receptor agonist for treating pulmonary fibrosis
WO2017221012A1 (en) 2016-06-21 2017-12-28 Vicore Pharma Ab Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity
GB201818164D0 (en) 2018-11-07 2018-12-19 Vicore Pharma Ab New composition
JP2022542437A (en) 2019-08-02 2022-10-03 ランティオペプ ベスローテン ヴェンノーツハップ Angiotensin type 2 (AT2) receptor agonists for treating cancer
GB201913603D0 (en) 2019-09-20 2019-11-06 Vicore Pharma Ab New compounds
WO2021186185A1 (en) 2020-03-19 2021-09-23 Vicore Pharma Ab Novel compounds useful in the treatment and/or prevention of a disease, disorder or condition associated with angiotensin ii
GB202004094D0 (en) 2020-03-20 2020-05-06 Vicore Pharma Ab New compounds and uses
GB202006081D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006074D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006079D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202013721D0 (en) 2020-09-01 2020-10-14 Vicore Pharma Ab New compounds
GB202104038D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
GB202104033D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
WO2022200785A1 (en) 2021-03-23 2022-09-29 Vicore Pharma Ab Selective angiotensin ii receptor ligands
EP4367110A1 (en) 2021-07-09 2024-05-15 Vicore Pharma AB New selective angiotensin ii compounds
GB202115303D0 (en) 2021-10-25 2021-12-08 Vicore Pharma Ab New formulation
GB202201723D0 (en) 2022-02-10 2022-03-30 Vicore Pharma Ab New use
WO2023152503A1 (en) 2022-02-10 2023-08-17 Vicore Pharma Ab Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis
KR20250002355A (en) 2022-04-06 2025-01-07 우한 휴먼웰 이노베이티브 드러그 리서치 앤드 디벨롭먼트 센터 리미티드 컴퍼니 AT2R agonist
WO2024133942A1 (en) 2022-12-22 2024-06-27 Vicore Pharma Ab A method of treating a patient diagnosed with an interstitial lung disease
JP2026502510A (en) 2023-01-09 2026-01-23 ヴィコール ファルマ アーベー Selective angiotensin II compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444067A (en) * 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
WO1996014060A1 (en) * 1994-11-04 1996-05-17 Marklund Stefan L Use of receptor agonists to stimulate superoxide dismutase activity
SE9501881D0 (en) * 1995-05-19 1995-05-19 Astra Ab New pharmacological use of AII receptor antagonists
US5834432A (en) * 1995-06-06 1998-11-10 The University Of Southern California Use of angiotensin II Type 2 receptor agonists in tissue repair
SE9502219D0 (en) * 1995-06-19 1995-06-19 Astra Ab Novel medical use

Also Published As

Publication number Publication date
EE200000481A (en) 2002-02-15
CN1291104A (en) 2001-04-11
ID26639A (en) 2001-01-25
AU2753799A (en) 1999-09-15
IL137990A0 (en) 2001-10-31
HUP0101411A3 (en) 2002-11-28
HUP0101411A2 (en) 2002-03-28
SK11522000A3 (en) 2001-04-09
MXPA00008172A (en) 2002-06-21
SE9800550D0 (en) 1998-02-24
NZ506188A (en) 2003-04-29
JP2002504516A (en) 2002-02-12
BR9908188A (en) 2000-10-24
WO1999043339A1 (en) 1999-09-02
KR20010041211A (en) 2001-05-15
EP1066048A1 (en) 2001-01-10
NO20004215L (en) 2000-09-18
AU755949B2 (en) 2003-01-02
NO20004215D0 (en) 2000-08-23
CA2319123A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
IS5594A (en) A pharmaceutical composition containing an angiotensin II receptor type 2 receptor agonist and its use
HUP0301083A3 (en) Synergistical herbicide composition and use thereof
HUP0201545A3 (en) Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them
NO20012411D0 (en) Pyrrolidine derivatives-CCR-3 receptor antagonists
IS5794A (en) A pharmaceutical composition containing COX-2 inhibitor and iNOS inhibitor
NO991151D0 (en) Compound and Use thereof
DK0945132T3 (en) Ibuprofen composition
HUP0104270A3 (en) Herbicidal composition and use thereof
EP1112252A4 (en) Kappa agonist compounds and pharmaceutical formulations thereof
ID29262A (en) PHARMACEUTICAL COMPOSITION
NO20006488D0 (en) Composition and application
DK1112003T3 (en) New composition and application
NO20010804D0 (en) Muscarinic agonists and antagonists
IL139865A0 (en) A liver selective glucocorticoid antagonist and pharmaceutical compositions containing the same
NO20004274D0 (en) Protease-activated receptor 4 and its use
MA26890A1 (en) EESTROGEN AGONIST / ANTAGONIST METABOLITES
NO20004277L (en) Indole derivatives and pharmaceutical compositions comprising the same
DE69935411D1 (en) TWO-COMPONENT TOOTHPASTE COMPOSITION AGAINST DENTAL PLATE
ID26086A (en) AZHTICICLIC 5HT1 RECEPTOR LIGANS
IL138576A0 (en) A novel interleukin-1 receptor antagonist and uses thereof
GB9820014D0 (en) Receptor antagonists and uses thereof
GB9803521D0 (en) New compounds and pharmaceutical compositions thereof
NO20012943D0 (en) New heterocyclic compounds and pharmaceutical compositions containing the same
BR9710568A (en) Pharmaceutical composition containing a 5Hht2c antagonist and a d2 antagonist
EP1124557A4 (en) PHARMACEUTICAL COMPOSITION